X Ray News and Research

RSS

Xstrahl launches new control system for X-ray therapy

Xstrahl, a designer and manufacturer of a world-renowned range of superficial and orthovoltage radiotherapy systems that have been essential in supporting healthcare professionals and their patients in over 500 clinics for the past 15 years, today announces the launch of Imperium, a new control system for its X-ray therapy system, at this year's ASTRO conference in San Diego, 31 October - 4 November.

From Xstrahl 1 Nov 2010

Joslin announces fundraisers to benefit diabetes research

The importance of the research and clinical care work at Joslin Diabetes Center in Boston has been affirmed by a report from the Centers for Disease Control and Prevention predicting that one-third of all U.S. adults will have diabetes by 2050 if current trends continue.

30 Oct 2010

OHSU to lead next phase of HuCNS-SC trial for NCL in children

Oregon Health & Science University Doernbecher Children's Hospital will lead the next phase of a landmark clinical trial to further assess the safety and preliminary effectiveness of purified human neural stem cells (HuCNS-SC-) as a potential treatment for infantile or late-infantile neuronal ceroid lipofuscinosis (NCL), a rare and currently fatal neurodegenerative disorder that affects infants and children.

30 Oct 2010

Research on brain circuit activity may pave way to find biomarker for PTSD

University of Minnesota Medical School and Minneapolis Veterans Affair Medical Center researchers have discovered a correlation between increased circuit activity in the right side of the brain and the debilitating, involuntary flashbacks triggered by post traumatic stress disorder (PTSD).

29 Oct 2010

Henry Ford Hospital physicist receives ASTRO's Basic Science Abstract Award

Henry Ford Hospital physicist Lei Ren, Ph.D., is among an elite group to be awarded for basic science research in radiation oncology at the 52nd annual American Society for Radiology Oncology (ASTRO) meeting in San Diego.

29 Oct 2010

Boston Scientific's Neurovascular business to be acquired by Stryker

Boston Scientific Corporation today announced the execution of a definitive agreement under which Stryker Corporation will acquire Boston Scientific's Neurovascular business. The purchase price is $1.5 billion, payable in cash, of which $1.4 billion is payable at closing and $100 million will be payable following the closing and upon the occurrence of the commercialization of the next-generation Target™ Detachable Coils and the transfer or separation of certain manufacturing facilities, which is anticipated to occur over a period of approximately 24 months.

From Stryker 29 Oct 2010

Bismuth for bone cement

Organic–inorganic hybrid materials, uniting the advantages of their organic and inorganic parts, are used for a wide variety of applications. However, making a homogeneous composite material is only possible if a solvent can be found in which both components are soluble.

28 Oct 2010

DENTSPLY 2010 third quarter net sales increases 2.0% to $541.8 million

DENTSPLY International Inc. today announced sales and earnings for the three months ended September 30, 2010.

28 Oct 2010

Mirada Medical and Moffitt Cancer Center enter joint development agreement

Mirada Medical Limited, the fast growing international company focused on advanced oncology imaging, announced today that they have signed an agreement with Moffitt Cancer Center, Tampa, FL, one of the USA's top centers for cancer treatment and oncology research.

28 Oct 2010

World's largest free-standing proton therapy center opens

Hampton University, along with the Honorable Gov. Bob McDonnell and hundreds of guests, celebrated the grand opening of the Hampton University Proton Therapy Institute (HUPTI), the world's largest free-standing proton center, on Thursday.

28 Oct 2010

Scientists determine tertiary structure of TehA membrane protein in Haemophilus bacteria

Proteins are molecular machines that transport substances, catalyze chemical reactions, pump ions, and identify signaling substances. They are chains of amino acids and the individual amino acid sequence is known for many of them. However, the functions a protein can carry out inside the cell are determined by the three-dimensional spatial structure of the protein. Establishing this so-called tertiary structure presents a great challenge to scientists.

28 Oct 2010

Horizon to distribute Hitachi MRI and CT Product Lines in Canada

Hitachi Medical Systems America (HMSA) is pleased to announce that they have signed an agreement with Horizon Medical Services Ltd., in Mississauga, Ontario to be their exclusive MRI and CT sales and service representative in Canada.

28 Oct 2010

New Australian start-up venture could lead to a revolution in personalized medicine

Pharmaceuticals that seek out cancerous cells and deliver treatments to them; imaging techniques that can help doctors detect diseases before the physical signs begin to appear; and medicines that are tailor-made for individual patients, are within the sights of an exciting new Australian start-up venture.

27 Oct 2010

New portable scanner for breast cancer diagnosis

Professor Zhipeng Wu has invented a portable scanner based on radio frequency technology, which is able to show in a second the presence of tumours malignant and benign in the breast on a computer.

From The University of Manchester 27 Oct 2010

Rush University awards $25 million contract to Siemens

Rush University Medical Center in Chicago, one of the top academic medical centers in the United States, has awarded a five-year, $25 million contract for medical equipment and health IT consulting services to Siemens Medical Solutions USA, Inc. With the addition of Siemens medical imaging equipment and software, Rush will become one of a select group of medical centers in the country incorporating the concept of an interventional platform within its facility.

From Siemens Healthineers 27 Oct 2010

Combination of radiation and hormone therapy improves survival rate among prostate cancer patients

Prostate cancer patients who are treated with a combination of hormone therapy and radiation have a substantially improved chance of survival compared to patients who do not receive radiation, according to interim results of the largest randomized study of its kind presented at the plenary session, November 1, 2010, at the 52nd Annual Meeting of the American Society for Radiation Oncology (ASTRO).

26 Oct 2010

IMRT minimizes gastrointestinal side effects of prostate cancer treatment

Men with prostate cancer treated with a specialized type of radiation called intensity modulated radiation therapy (IMRT) have fewer gastrointestinal complications compared to patients treated with conventional three-dimensional conformal radiotherapy (3D-CRT), according to a study presented November 1, 2010, at the 52nd Annual Meeting of the American Society for Radiation Oncology (ASTRO).

26 Oct 2010

72% of patients misdiagnosed with pneumonia upon readmission : Study

Patients were misdiagnosed with pneumonia at an alarming rate when they were readmitted to the hospital shortly after a previous hospitalization for the same illness, according to two Henry Ford Hospital companion studies.

25 Oct 2010

Researchers find new minimally invasive option to determine natural causes of death

Researchers found that the combination of computed tomography (CT), postmortem CT angiography (CTA) and biopsy can serve as a minimally invasive option for determining natural causes of death such as cardiac arrest, according to a study in the November issue of the American Journal of Roentgenology.

22 Oct 2010

Highlights of Frontiers in Optics 2010/Laser Science XXVI Meeting

Scientists and engineers from around the world will gather on the shores of Lake Ontario in Rochester, N.Y. next week to discuss some of the latest breakthroughs in lasers and optics and their applications to cutting-edge science, the development of new materials, and medicine.

21 Oct 2010